# A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects

> **NCT01497288** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 20 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** INFS (Intranasal Fentanyl Spray)

## Key facts

- **NCT ID:** NCT01497288
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01497288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01497288, "A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01497288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*